Literature DB >> 6220984

The effect of PS-K, a protein bound polysaccharide, on immune responses against allogeneic antigens.

M J Ehrke, J M Reino, C Eppolito, E Mihich.   

Abstract

A single dose of PS-K administered to C57B1/6J mice after immunization augmented both the humoral and cellular allogeneic responses against P815 tumor cells. PS-K addition to primary alloantigen sensitization cultures (C57B1/6J spleen cells against X-irradiated P815 cells) resulted in augmented 3H-thymidine uptake and cell mediated cytolytic activity. Ten daily administrations of PS-K to DBA/2J mice after implantation of a mammary tumor of DBA/2HaDD origin results in increased tumor regression and prolonged survival of the mice. PS-K addition to human mixed lymphocyte cultures caused an augmentation of both cell mediated cytolytic activity and 3H thymidine uptake. The dose dependence of the PS-K effects were described by a bell shaped curve and PS-K did not appear to affect the day of peak development of the various responses. The effects were consistently greater if PS-K was administered at the same time or after antigen presentation. Thus, the immunoaugmenting effects induced by PS-K were similar in each model system tested.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6220984     DOI: 10.1016/0192-0561(83)90069-3

Source DB:  PubMed          Journal:  Int J Immunopharmacol        ISSN: 0192-0561


  7 in total

1.  ECA39 is a novel distant metastasis-related biomarker in colorectal cancer.

Authors:  Reigetsu Yoshikawa; Hidenori Yanagi; Chun-Shen Shen; Yoshinori Fujiwara; Masafumi Noda; Toshihiko Yagyu; Makoto Gega; Tsutomu Oshima; Takehira Yamamura; Haruki Okamura; Yoshiro Nakano; Tomonori Morinaga; Tomoko Hashimoto-Tamaoki
Journal:  World J Gastroenterol       Date:  2006-09-28       Impact factor: 5.742

2.  The therapeutic effects of an immunopotentiator, PS-K, on 3-methylcholanthrene-induced autochthonous tumors in C57BL/6 mice in combination with the surgical removal of primary sites.

Authors:  M Hosokawa; T Mizukoshi; K Morikawa; Z Y Xu; H Kobayashi
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

3.  Potentiation of T cell immunity against radiation-leukemia-virus-induced lymphoma by polysaccharide K.

Authors:  E Yefenof; E Einat; E Klein
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

4.  In vitro immunomodulating effect of protein-bound polysaccharide, PSK on peripheral blood, regional nodes, and spleen lymphocytes in patients with gastric cancer.

Authors:  Y Nio; T Shiraishi; M Tsubono; H Morimoto; C C Tseng; S Imai; T Tobe
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

5.  Prophylactic intervention in radiation-leukemia-virus-induced murine lymphoma by the biological response modifier polysaccharide K.

Authors:  E Yefenof; I Gafanovitch; E Oron; M Bar; E Klein
Journal:  Cancer Immunol Immunother       Date:  1995-12       Impact factor: 6.968

Review 6.  Immunoceuticals: Harnessing Their Immunomodulatory Potential to Promote Health and Wellness.

Authors:  Sophie Tieu; Armen Charchoglyan; Lauri Wagter-Lesperance; Khalil Karimi; Byram W Bridle; Niel A Karrow; Bonnie A Mallard
Journal:  Nutrients       Date:  2022-09-30       Impact factor: 6.706

7.  Lysis of fresh human tumor cells by autologous peripheral blood lymphocytes and tumor-infiltrating lymphocytes activated by PSK.

Authors:  Y Kariya; N Okamoto; T Fujimoto; N Inoue; T Kihara; K Sugie; M Yagita; H Kanzaki; T Mori; A Uchida
Journal:  Jpn J Cancer Res       Date:  1991-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.